Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cells after acute myocardial infarction
NL-OMON24674Recruiting
- Sponsor
- Investigator-initiated study. Principal investigator: dr. D.E. Atsma
- Start
- Jan 2006
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow derived mesenchymal stromal cells in myocardial infarction (MI), sponsored by Investigator-initiated study. Principal investigator: dr. D.E. Atsma. Primary endpoint: Safety and feasibility. Started Jan 2006; status: recruiting.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON24674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24674.